HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SKB BIO

523.000

-15.000-2.79%

Volume:545.54K

Turnover:285.59M

Market Cap:125.00B

PE:-270.86

High:543.000

Open:540.000

Low:516.500

Close:538.000

52wk High:581.000

52wk Low:339.600

Shares:239.00M

HK Float Shares:177.00M

Volume Ratio:0.74

T/O Rate:0.31%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.931

ROE:2.92%

ROA:0.03%

PB:20.10

PE(LYR):-270.86

PS:51.42

Loading ...

Overview Company News Filings

科伦博泰2025年度核心业绩与业务综述：营收稳步增长，研发投入持续加大

Bulletin Express

China International Capital Corporation: National Policy Optimizes Initial Pricing Mechanism for Innovative Drugs, Pharmaceutical Sector Set for High-Quality Development

BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Subscribes To CZB Structured Deposit II For RMB100 MLN On Apr 15

Kelun-Bota Biotech Invests in Structured Deposits Totaling 690 Million Yuan

Kelun-Biotech commits RMB 690 million to principal-guaranteed structured deposits with CZB and BOC

Bulletin Express

Sichuan Kelun-Biotech Biopharmaceutical - Subscribes to Czb Structured Deposit Ii for RMB100 Mln on Apr 15

THOMSON REUTERS

Kelun-Biotech sac-TMT plus Keytruda posts 51% ORR in cervical cancer trial cohort

Kelun-Biotech Announces Results From the Skb264-Ii-06/Mk-2870-002 Study of Sacituzumab Tirumotecan (Sac-TMT) in Gynecologic Oncology Presented at 2026 Sgo

THOMSON REUTERS

Kelun-Biotech Maintains Stable Share Structure in March 2026 Monthly Return

Bulletin Express

Kelun-Biotech total issued shares unchanged at 233,185,969 as of March-end

Kelun-Biotech (SKB BIO-B) Secures HKEX Nod for Full H-Share Circulation, Converting 8.21 Million Shares

Bulletin Express

SKB BIO-B Receives Hong Kong Exchange Approval for Full H-Share Circulation

Kelun-Biotech wins Hong Kong approval for 8,214,278 H-share full circulation conversion

A Look At Kelun-Biotech’s Valuation As SKB103 Gains China Regulatory Green Light

Simply Wall St.

A Look At Sichuan Kelun Biotech (SEHK:6990) Valuation After SKB103 IND Approval And Pipeline Progress

Simply Wall St.

SKB BIO-B Receives CSRC Filing Notice for H-Share Full Circulation

Sichuan Kelun-Biotech receives CSRC filing notice for H-share full circulation; conversion and listing plan pending finalization

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Simply Wall St.

Sichuan Kelun-Biotech’s SKB103 IND Adds ADC Momentum And Valuation Upside

Simply Wall St.

Sichuan Kelun‑Biotech (SEHK:6990) Losses Narrow In 1H 2025 Challenging Bearish Narratives

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/06990/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO","latestPrice":523,"timestamp":1787558901008,"preClose":538,"halted":0,"volume":545535,"delay":0,"changeRate":-0.027881040892193308,"floatShares":177000000,"shares":239000000,"eps":-1.9309147534264823,"marketStatus":"Closed","change":-15,"latestTime":"08-24 16:08:21","open":540,"high":543,"low":516.5,"amount":285594684,"amplitude":0.049257,"askPrice":523,"askSize":200,"bidPrice":522.5,"bidSize":800,"shortable":3,"etf":0,"ttmEps":0.7554555526491077,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787621400000},"marketStatusCode":5,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":538,"openAndCloseTimeList":[[1787535000000,1787544000000],[1787547600000,1787558400000]],"volumeRatio":0.740808,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":177000000,"roa":"0.03%","roe":"2.92%","lyrEps":-1.930915,"volumeRatio":0.740808,"shares":239000000,"dividePrice":0,"high":543,"amplitude":0.049257,"preClose":538,"low":516.5,"week52Low":339.6,"pbRate":"20.10","psRate":"51.42","week52High":581,"institutionHeld":0,"latestPrice":523,"committee":0.6,"eps":-1.9309147534264823,"divideRate":0,"volume":545535,"delay":0,"ttmEps":0.7554555526491077,"open":540,"prevYearClose":392.2,"prevWeekClose":538,"prevMonthClose":483.8,"prevQuarterClose":436.2,"fiveDayClose":522.5,"twentyDayClose":513.5,"sixtyDayClose":447},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2026-08-17","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786930200000,"name":null,"time":"","dateTimestamp":1786896000000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"06990","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post-Mkt","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"Post-Mkt","dateTimestamp":1723996800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":21,"updateTime":1786636800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2026-08-21","current":692.26888,"percent":0.998696,"low":-351.800852,"twenty":-236.676246,"median":-135.748112,"eighty":-53.902639,"high":737.230287,"avg":-137.360118,"sd":103.774207,"marketCap":128594895322},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-07","current":-120.930715,"twenty":-203.710245,"median":-131.985022,"eighty":-48.610423,"marketCap":95373061321},{"date":"2025-11-14","current":-137.099974,"twenty":-201.138492,"median":-131.729362,"eighty":-48.622244,"marketCap":108431475585},{"date":"2025-11-21","current":-125.836792,"twenty":-194.360264,"median":-130.233026,"eighty":-48.651606,"marketCap":99477134375},{"date":"2025-11-28","current":-134.139839,"twenty":-194.090443,"median":-131.64896,"eighty":-48.675637,"marketCap":106426076251},{"date":"2025-12-05","current":-134.965867,"twenty":-192.863217,"median":-131.473703,"eighty":-48.751223,"marketCap":107265545740},{"date":"2025-12-12","current":-128.449432,"twenty":-188.527876,"median":-130.526276,"eighty":-48.814858,"marketCap":102275366003},{"date":"2025-12-19","current":-122.479247,"twenty":-187.446049,"median":-129.499037,"eighty":-48.911385,"marketCap":97751558204},{"date":"2025-12-24","current":-122.098928,"twenty":-187.290368,"median":-128.758533,"eighty":-48.913338,"marketCap":97751558204},{"date":"2026-01-02","current":-116.223952,"twenty":-179.729041,"median":-128.478737,"eighty":-49.104524,"marketCap":93414299181},{"date":"2026-01-09","current":-137.872108,"twenty":-173.799059,"median":-128.508043,"eighty":-49.251224,"marketCap":111089795631},{"date":"2026-01-16","current":-136.67551,"twenty":-173.152374,"median":-129.252083,"eighty":-49.296233,"marketCap":110483512112},{"date":"2026-01-23","current":-124.044288,"twenty":-172.874196,"median":-128.511935,"eighty":-49.590244,"marketCap":100176692282},{"date":"2026-01-30","current":-119.398299,"twenty":-172.654145,"median":-128.43808,"eighty":-50.08289,"marketCap":96865451522},{"date":"2026-02-06","current":-121.3325,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"marketCap":98684302080},{"date":"2026-02-13","current":-119.328264,"twenty":-171.604872,"median":-127.229577,"eighty":-50.349599,"marketCap":97611646623},{"date":"2026-02-20","current":-118.929435,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"marketCap":97145274685},{"date":"2026-02-27","current":-109.393801,"twenty":-170.608939,"median":-126.362178,"eighty":-50.420375,"marketCap":90336244390},{"date":"2026-03-06","current":-109.941252,"twenty":-169.952459,"median":-125.237252,"eighty":-50.5225,"marketCap":90056421227},{"date":"2026-03-13","current":-111.874188,"twenty":-169.826622,"median":-125.028422,"eighty":-50.583009,"marketCap":92061820561},{"date":"2026-03-20","current":-118.784792,"twenty":-169.647858,"median":-124.510593,"eighty":-50.752344,"marketCap":97378460654},{"date":"2026-03-27","current":-246.717525,"twenty":-170.608939,"median":-124.791344,"eighty":-50.880899,"marketCap":106705913600},{"date":"2026-04-02","current":-270.1664,"twenty":-172.638036,"median":-125.053164,"eighty":-50.929189,"marketCap":117409151000},{"date":"2026-04-10","current":-262.507699,"twenty":-173.162671,"median":-125.237252,"eighty":-50.974222,"marketCap":114960698000},{"date":"2026-04-17","current":-276.768173,"twenty":-188.270393,"median":-126.362178,"eighty":-51.053793,"marketCap":121256720000},{"date":"2026-04-24","current":-263.25072,"twenty":-199.457552,"median":-126.777731,"eighty":-51.109685,"marketCap":115341038016},{"date":"2026-04-30","current":-249.758244,"twenty":-207.783795,"median":-127.598017,"eighty":-51.131881,"marketCap":109457493848},{"date":"2026-05-08","current":-237.123047,"twenty":-214.424086,"median":-128.140667,"eighty":-51.206724,"marketCap":104280765336},{"date":"2026-05-15","current":-230.895214,"twenty":-220.549694,"median":-128.478737,"eighty":-51.422215,"marketCap":101808994065},{"date":"2026-05-22","current":-251.35436,"twenty":-225.355554,"median":-129.00513,"eighty":-51.539533,"marketCap":110576786499},{"date":"2026-05-29","current":-244.039033,"twenty":-227.151092,"median":-129.499037,"eighty":-51.775379,"marketCap":107731917678},{"date":"2026-06-05","current":-207.501784,"twenty":-227.151092,"median":-130.526276,"eighty":-51.91711,"marketCap":91735360204},{"date":"2026-06-12","current":-219.148588,"twenty":-226.740676,"median":-131.473703,"eighty":-52.267792,"marketCap":96818814328},{"date":"2026-06-18","current":-218.939992,"twenty":-226.404961,"median":-131.824218,"eighty":-52.561632,"marketCap":96958725910},{"date":"2026-06-26","current":-221.178526,"twenty":-225.594566,"median":-132.326202,"eighty":-52.73121,"marketCap":97471735042},{"date":"2026-07-03","current":-263.841103,"twenty":-227.197711,"median":-132.771691,"eighty":-52.93717,"marketCap":116359798531},{"date":"2026-07-10","current":-273.42961,"twenty":-228.864297,"median":-133.50718,"eighty":-53.148078,"marketCap":120440552988},{"date":"2026-07-17","current":-263.005613,"twenty":-229.666754,"median":-134.182751,"eighty":-53.480935,"marketCap":116261258521},{"date":"2026-07-24","current":-277.867014,"twenty":-230.754675,"median":-134.677954,"eighty":-54.022455,"marketCap":122858320066},{"date":"2026-07-31","current":-261.04507,"twenty":-231.704791,"median":-134.965867,"eighty":-54.274788,"marketCap":115639796202},{"date":"2026-08-07","current":-290.535115,"twenty":-235.013451,"median":-135.70577,"eighty":-54.298503,"marketCap":128953431275},{"date":"2026-08-14","current":-279.9487,"twenty":-236.676246,"median":-136.101797,"eighty":-54.329175,"marketCap":124411975864},{"date":"2026-08-21","current":729.337059,"twenty":-236.676246,"median":-135.748112,"eighty":-53.902639,"marketCap":128594895322}],"updateTime":1787559338474},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1116846497","title":"科伦博泰2025年度核心业绩与业务综述：营收稳步增长，研发投入持续加大","url":"https://stock-news.laohu8.com/highlight/detail?id=1116846497","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116846497?lang=en_us&edition=fundamental","pubTime":"2026-04-16 23:07","pubTimestamp":1776352067,"startTime":"0","endTime":"0","summary":"科伦博泰（SKB BIO-B）于2025年度在核心业务和研发领域实现多项突破，进一步加速由生物技术企业向具备药品研发与商业化一体化能力的生物制药企业转型。根据年度报告及相关章节内容，主要年度亮点和变化如下： 一、经营业绩与财务表现...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124678664","title":"China International Capital Corporation: National Policy Optimizes Initial Pricing Mechanism for Innovative Drugs, Pharmaceutical Sector Set for High-Quality Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1124678664","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124678664?lang=en_us&edition=fundamental","pubTime":"2026-04-16 14:39","pubTimestamp":1776321543,"startTime":"0","endTime":"0","summary":"China International Capital Corporation (CICC) has released a research report stating that on April 14th, the General Office of the State Council issued the \"Several Opinions on Improving the Drug...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1589","LU0348735423.USD","BK1574","LU2488822045.USD","BK1161","HK0000500386.USD","BK1191","06990","BK1583","HK0000252152.HKD","01801","LU0348827113.USD","09606","LU0307460666.USD","LU0417516902.SGD","BK1500","BK1588","LU1770034418.SGD","LU1023057109.AUD","LU2097828474.EUR","LU1794554557.SGD","LU2097828805.USD","LU0348784397.USD","09926","LU2778985437.USD","LU0634319403.HKD","IE00B543WZ88.USD","LU0348825331.USD","LU2328871848.SGD","LU0561508036.HKD","LU1969619763.USD","IE00BPRC5H50.USD","HK0000165453.HKD","LU0359201612.USD","LU0540923850.HKD","LU2543165471.USD","LU1961090484.USD","LU0588546209.SGD","LU2097828714.EUR","LU0455707207.USD","LU0359201885.HKD","LU0417516571.SGD","06978","LU2399975544.HKD","LU0359202008.SGD","HK0000252160.HKD","LU0417516738.SGD","LU0502904849.HKD","LU1719994722.HKD","LU2476274308.USD","LU0348783233.USD","LU2097828557.USD","LU2097828631.EUR","LU1303224171.USD","06160","LU0196878994.USD","LU1720050803.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","IPOS","LU0348766576.USD","LU2242644610.SGD","LU0348767384.USD","01276","LU1251922891.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627537238","title":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Subscribes To CZB Structured Deposit II For RMB100 MLN On Apr 15","url":"https://stock-news.laohu8.com/highlight/detail?id=2627537238","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627537238?lang=en_us&edition=fundamental","pubTime":"2026-04-15 22:01","pubTimestamp":1776261700,"startTime":"0","endTime":"0","summary":"BRIEF-Sichuan Kelun-Biotech Biopharmaceutical Subscribes To CZB Structured Deposit II For RMB100 MLN On Apr 15April 15  - Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 6990.HK:SUBSCRIBES TO CZB STRUCTURED DEPOSIT II FOR RMB100 MILLION ON APR 15Further company coverage: 6990.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y07P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100678781","title":"Kelun-Bota Biotech Invests in Structured Deposits Totaling 690 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1100678781","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100678781?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:44","pubTimestamp":1776257055,"startTime":"0","endTime":"0","summary":"Kelun-Bota Biotech (06990) announced that on January 19, 2026, the company entered into the CZBANK Structured Deposit Agreement I, under which it agreed to subscribe for a CZBANK structured deposit I...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02016","BK1560","LU0196878994.USD","BK0278","601916","BK1231","BK1161","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193413318","title":"Kelun-Biotech commits RMB 690 million to principal-guaranteed structured deposits with CZB and BOC","url":"https://stock-news.laohu8.com/highlight/detail?id=1193413318","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193413318?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:43","pubTimestamp":1776256998,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Kelun-Biotech) disclosed that it has placed a combined RMB 690.00 million in principal-guaranteed, floating-rate structured deposits at China...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627842252","title":"Sichuan Kelun-Biotech Biopharmaceutical - Subscribes to Czb Structured Deposit Ii for RMB100 Mln on Apr 15","url":"https://stock-news.laohu8.com/highlight/detail?id=2627842252","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627842252?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:36","pubTimestamp":1776256578,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y07P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627464254","title":"Kelun-Biotech sac-TMT plus Keytruda posts 51% ORR in cervical cancer trial cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2627464254","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627464254?lang=en_us&edition=fundamental","pubTime":"2026-04-14 08:00","pubTimestamp":1776124819,"startTime":"0","endTime":"0","summary":"Kelun-Biotech disclosed Phase II SKB264-II-06/MK-2870-002 results for TROP2 ADC sacituzumab tirumotecan  with Merck’s pembrolizumab in ovarian cancer, cervical cancer.Data were presented at 2026 Society of Gynecologic Oncology Annual Meeting, based on analyses cut off Nov. 17, 2025.Ovarian cancer cohort showed treatment extended disease control in maintenance setting for BRCA wild-type, second-line platinum-sensitive recurrent disease.Cervical cancer cohort showed meaningful tumor shrinkage in previously treated recurrent or metastatic disease, including patients with prior immunotherapy.Safety profile was described as manageable across both cohorts, with no treatment-related deaths reported.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL459YCd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","BK0239","LU2148510915.USD","LU0196878994.USD","LU1979443071.USD","BK0060","06990","LU1934453819.USD","002422","LU1064130708.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627464287","title":"Kelun-Biotech Announces Results From the Skb264-Ii-06/Mk-2870-002 Study of Sacituzumab Tirumotecan (Sac-TMT) in Gynecologic Oncology Presented at 2026 Sgo","url":"https://stock-news.laohu8.com/highlight/detail?id=2627464287","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627464287?lang=en_us&edition=fundamental","pubTime":"2026-04-14 08:00","pubTimestamp":1776124800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nTUAC2TCS8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","BK1161","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100945432","title":"Kelun-Biotech Maintains Stable Share Structure in March 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1100945432","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100945432?lang=en_us&edition=fundamental","pubTime":"2026-04-09 16:41","pubTimestamp":1775724073,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (H-share abbreviation: Kelun-Biotech) reported no changes in authorised, registered or issued share capital for the month ended 31 March 2026. •...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626024739","title":"Kelun-Biotech total issued shares unchanged at 233,185,969 as of March-end","url":"https://stock-news.laohu8.com/highlight/detail?id=2626024739","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626024739?lang=en_us&edition=fundamental","pubTime":"2026-04-09 16:33","pubTimestamp":1775723605,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech reported 162,769,979 issued H shares as of March 31, 2026.Total issued shares across all classes stood at 233,185,969 at month-end.Treasury shares were 0 across all share classes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL58k48j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1979443071.USD","BK0060","06990","LU0196878994.USD","LU1064130708.USD","LU1064131003.USD","LU1934453819.USD","BK0239","002422","LU2148510915.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161871922","title":"Kelun-Biotech (SKB BIO-B) Secures HKEX Nod for Full H-Share Circulation, Converting 8.21 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1161871922","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161871922?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:21","pubTimestamp":1775654495,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO-B) has received Hong Kong Stock Exchange approval to convert and list 8.21 million domestic and unlisted foreign shares as H shares under...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116946169","title":"SKB BIO-B Receives Hong Kong Exchange Approval for Full H-Share Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=1116946169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116946169?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:14","pubTimestamp":1775654087,"startTime":"0","endTime":"0","summary":"SKB BIO-B (06990) has announced that the company applied to the Hong Kong Stock Exchange for the listing and trading approval of 8.2143 million H-shares, equivalent to the total number of domestic...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0196878994.USD","06990","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625827944","title":"Kelun-Biotech wins Hong Kong approval for 8,214,278 H-share full circulation conversion","url":"https://stock-news.laohu8.com/highlight/detail?id=2625827944","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625827944?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:03","pubTimestamp":1775653396,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical secured Stock Exchange listing clearance for H-share full circulation covering 8,214,278 converted H shares.Converted H shares represent about 3.5% of total share capital based on current capital structure.H-share portion is set to rise to 73.3% from 69.8% once conversion and listing complete.Company plans to complete conversion and trading procedures for converted H shares, with further progress updates to follow.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 08, 2026, and is solely responsi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL96Sxk2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934453819.USD","BK0060","LU0196878994.USD","LU1979443071.USD","BK0239","LU2148510915.USD","LU1064131003.USD","06990","LU1064130708.USD","BK1161","002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625672413","title":"A Look At Kelun-Biotech’s Valuation As SKB103 Gains China Regulatory Green Light","url":"https://stock-news.laohu8.com/highlight/detail?id=2625672413","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625672413?lang=en_us&edition=fundamental","pubTime":"2026-04-06 18:14","pubTimestamp":1775470481,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) just received clearance from China’s drug regulator to begin clinical development of SKB103, its first TAA PD L1 bispecific antibody drug conjugate for advanced solid tumors.\nSee our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical.\nThe SKB103 news arrives after a strong run in the shares, with a 30 day share price return of 30.37% and a year to date share price return of 25.69%. The 1 year total shareholder return of 108.06%...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/a-look-at-kelun-biotechs-valuation-as-skb103-gains-china-reg","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/a-look-at-kelun-biotechs-valuation-as-skb103-gains-china-reg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","06990","BK1161","BK4585","LU0196878994.USD","DCF","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623364706","title":"A Look At Sichuan Kelun Biotech (SEHK:6990) Valuation After SKB103 IND Approval And Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2623364706","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623364706?lang=en_us&edition=fundamental","pubTime":"2026-03-30 08:19","pubTimestamp":1774829944,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) just received Chinese regulator approval for its SKB103 IND in advanced solid tumors, marking a new clinical milestone that comes alongside recent earnings and oncology trial updates.\nSee our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical.\nThe regulatory green light for SKB103 comes after a series of oncology updates and full-year 2025 results. The share price has reacted, with a 7.07% 1-day share price return and 18.12% 30-day...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/a-look-at-sichuan-kelun-biotech-sehk6990-valuation-after-skb","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/a-look-at-sichuan-kelun-biotech-sehk6990-valuation-after-skb","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","LU0196878994.USD","PRGS","XBI","BK4588","LU2065732104.USD","BK4581","BK4585","DCF","06990","IND","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198601910","title":"SKB BIO-B Receives CSRC Filing Notice for H-Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=1198601910","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198601910?lang=en_us&edition=fundamental","pubTime":"2026-03-27 23:16","pubTimestamp":1774624577,"startTime":"0","endTime":"0","summary":"SKB BIO-B (06990) has announced that the company received a filing notice from the China Securities Regulatory Commission (CSRC) dated March 26, 2026, regarding the implementation of an H-share full...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622189820","title":"Sichuan Kelun-Biotech receives CSRC filing notice for H-share full circulation; conversion and listing plan pending finalization","url":"https://stock-news.laohu8.com/highlight/detail?id=2622189820","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622189820?lang=en_us&edition=fundamental","pubTime":"2026-03-27 22:18","pubTimestamp":1774621131,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech receives CSRC filing notice for H-share full circulation; conversion and listing plan pending finalization. Kelun-Biotech received a filing notice from the CSRC confirming completion of its filing for an H-share full circulation involving 8,214,278 shares.The filing covers the conversion of up to 3,572,088 domestic shares and 4,642,190 unlisted foreign shares into H shares for listing.Implementation details for the full circulation plan and the conversion and listing have not been finalized.The company said it will provide updates as the process progresses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. published the original content used to generate this news brie","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL6MmZsf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0196878994.USD","LU1064130708.USD","LU2148510915.USD","LU1979443071.USD","BK0060","LU1934453819.USD","002422","06990","LU1064131003.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622120458","title":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990) Analysts Are Cutting Their Estimates: Here's What You Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2622120458","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622120458?lang=en_us&edition=fundamental","pubTime":"2026-03-27 13:07","pubTimestamp":1774588024,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ( HKG:6990 ) just released its full-year report and things are...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/sichuan-kelun-biotech-biopharmaceutical-co-ltd-hkg6990-analy","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/sichuan-kelun-biotech-biopharmaceutical-co-ltd-hkg6990-analy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["06990","BK4581","BK1161","XBI","BK4585","BK4588","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622586668","title":"Sichuan Kelun-Biotech’s SKB103 IND Adds ADC Momentum And Valuation Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2622586668","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622586668?lang=en_us&edition=fundamental","pubTime":"2026-03-26 13:02","pubTimestamp":1774501377,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) has received IND approval in China for SKB103, its first TAA PD-L1 bispecific antibody-drug conjugate.\nSKB103 becomes the company’s second bispecific ADC to reach the clinical stage, following SKB571.\nThe candidate is built on Kelun-Biotech’s proprietary OptiDC™ platform and is designed to combine tumor antigen targeting with PD-L1 immune modulation.\n\nFor investors tracking SEHK:6990, the IND clearance for SKB103 adds another clinical stage...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/sichuan-kelun-biotechs-skb103-ind-adds-adc-momentum-and-valu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/sichuan-kelun-biotechs-skb103-ind-adds-adc-momentum-and-valu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["06990","ADC","BK4231","BK1161","BK4581","BK4080","XBI","IND","BK4585","BK4588","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622041634","title":"Sichuan Kelun‑Biotech (SEHK:6990) Losses Narrow In 1H 2025 Challenging Bearish Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2622041634","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622041634?lang=en_us&edition=fundamental","pubTime":"2026-03-25 10:04","pubTimestamp":1774404276,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) has reported FY 2025 first half revenue of C¥950.4 million with a basic EPS loss of C¥0.64, while trailing twelve month revenue stands at C¥2.1 billion and basic EPS over that period is a loss of C¥3.20. The company has seen revenue move from C¥1.38 billion in 1H 2024 to C¥550.3 million in 2H 2024 and C¥950.4 million in 1H 2025, with EPS shifting from a profit of C¥1.41 in 1H 2024 to losses of C¥2.59 in 2H 2024 and C¥0.64 in 1H 2025...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/sichuan-kelunbiotech-sehk6990-losses-narrow-in-1h-2025-chall","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/sichuan-kelunbiotech-sehk6990-losses-narrow-in-1h-2025-chall","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","06990","BK1161","BK4585","LU0196878994.USD","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}